Veracyte | VCYT - Cash And Equivalent

Stock Price
36.16
Daily Change
1.30 3.73%
Monthly
-19.84%
Yearly
-12.99%
Q1 Forecast
36.91

Veracyte reported $315.57M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Arrowhead Research USD 201.64M 112.94M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Exact Sciences USD 789.04M 131.94M Sep/2025
Illumina USD 1.42B 368M Dec/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Ligand Pharmaceuticals USD 664.52M 596.85M Sep/2025
Myriad Genetics USD 145.4M 71M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Siemens EUR 14.64B 1.96B Jun/2025
Sonic Healthcare AUD 645M 25.39M Jun/2024
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Veracyte USD 315.57M 96.07M Sep/2025
Waters USD 459.12M 91.9M Sep/2025